132 related articles for article (PubMed ID: 2706964)
21. [Letter: Lasting depigmentation caused by hydroquinonemonobenzylether].
Fitzpatrick B
Hautarzt; 1975 Jan; 26(1):56. PubMed ID: 1116947
[No Abstract] [Full Text] [Related]
22. 'Fade out' photochromonychia.
Coulson IH
Clin Exp Dermatol; 1993 Jan; 18(1):87-8. PubMed ID: 8440066
[TBL] [Abstract][Full Text] [Related]
23. Probable allergic contact dermatitis from hydroquinone presenting as leukomelanoderma: Report of two cases.
Yanagishita-Nakatsuji S; Fukai K; Ohyama A; Umekoji A; Sowa-Osako J; Tsuruta D
J Dermatol; 2017 Dec; 44(12):e330-e331. PubMed ID: 28815722
[No Abstract] [Full Text] [Related]
24. [Cosmetic use of skin depigmentation products in Africa].
Del Giudice P; Raynaud E; Mahé A
Bull Soc Pathol Exot; 2003 Jan; 96(5):389-93. PubMed ID: 15015845
[TBL] [Abstract][Full Text] [Related]
25. Current contact news. Hydroquinone uses and abnormal reactions.
Fisher AA
Cutis; 1983 Mar; 31(3):240-4, 250. PubMed ID: 6220868
[No Abstract] [Full Text] [Related]
26. [Leucodermia acquisita areata caused by monobenzylether of hydroquinone (author's transl)].
Hegyi E; Valková P; Mat'oska J
Cesk Dermatol; 1979 Feb; 54(1):6-8. PubMed ID: 761240
[No Abstract] [Full Text] [Related]
27. Hydroquinone--a harmful agent.
Fernandes D
S Afr Med J; 2000 Sep; 90(9):829. PubMed ID: 11081118
[No Abstract] [Full Text] [Related]
28. Hydroquinone-induced exogenous ochronosis in Chinese--two case reports and a review.
Tan SK; Sim CS; Goh CL
Int J Dermatol; 2008 Jun; 47(6):639-40. PubMed ID: 18477169
[No Abstract] [Full Text] [Related]
29. [Exogenous ochronosis, a little-known side effect of hydroquinone-containing ointments].
Menke HE; Dekker SK; Noordhoek Hegt V; Pavel S; Westerhof W
Ned Tijdschr Geneeskd; 1992 Jan; 136(4):187-90. PubMed ID: 1736131
[TBL] [Abstract][Full Text] [Related]
30. Safety of over-the-counter hydroquinone bleaching creams.
Brauer EW
Arch Dermatol; 1985 Oct; 121(10):1239. PubMed ID: 4037812
[No Abstract] [Full Text] [Related]
31. Ochronosis following skin bleaching with hydroquinone.
Findlay GH
J Am Acad Dermatol; 1982 Jun; 6(6):1092-3. PubMed ID: 7096673
[No Abstract] [Full Text] [Related]
32. Q-Switched Alexandrite Laser and Topical 20% Monobenzyl Ester of Hydroquinone Removal of Tacrolimus-Induced Repigmentation (After Complete Depigmentation With 20% Monobenzyl Ether of Hydroquinone).
McGuinn KP; Saedi N; Green JB; Dover JS
Dermatol Surg; 2019 May; 45(5):756-757. PubMed ID: 30893165
[No Abstract] [Full Text] [Related]
33. Leucoderma induced by monomethyl ether of hydroquinone.
Boyle J; Kennedy CT
Clin Exp Dermatol; 1985 Mar; 10(2):154-8. PubMed ID: 3978862
[No Abstract] [Full Text] [Related]
34. Contact depigmentation of the breast.
Bajaj AK; Gupta SC; Chatterjee AK
Contact Dermatitis; 1991 Jan; 24(1):58. PubMed ID: 1842336
[No Abstract] [Full Text] [Related]
35. Ochronosislike pigmentation from hydroquinone bleaching creams in American blacks.
Hoshaw RA; Zimmerman KG; Menter A
Arch Dermatol; 1985 Jan; 121(1):105-8. PubMed ID: 3966811
[TBL] [Abstract][Full Text] [Related]
36. Monotertiary butyl hydroquinone in lipstick.
Calnan CD
Contact Dermatitis; 1981 Sep; 7(5):280. PubMed ID: 7307494
[No Abstract] [Full Text] [Related]
37. Exogenous ochronosis from hydroquinone bleaching cream.
Fisher AA
Cutis; 1998 Jul; 62(1):11-2. PubMed ID: 9675524
[No Abstract] [Full Text] [Related]
38. Cosmetic ochronosis caused by bleaching creams containing 2% hydroquinone.
Weiss RM; del Fabbro E; Kolisang P
S Afr Med J; 1990 Apr; 77(7):373. PubMed ID: 2321111
[No Abstract] [Full Text] [Related]
39. The safety of bleaching creams containing hydroquinone.
Fisher AA
Cutis; 1998 Jun; 61(6):303-4. PubMed ID: 9640546
[No Abstract] [Full Text] [Related]
40. Contact depigmentation by adhesive material of bindi.
Mathur AK; Srivastava AK; Singh A; Gupta BN
Contact Dermatitis; 1991 Apr; 24(4):310-1. PubMed ID: 1868725
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
